Astrantus »

Cme shares owned by Astrantus

Quarter-by-quarter ownership of Cme (CME) shares owned by Astrantus from 13F filings

Historical chart of Astrantus investment in Cme

Tip: Access up to 7 years of quarterly data

All positions including Cme held by Astrantus consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cme by Astrantus

Quarter filed Position value Share count Share price at filing
2022-03-31 $381k 1.6k 238.13
2021-12-31 $206k 900 228.89

More positions owned by Astrantus

Visa Inc. Class A Cl A (V)
Vale (VALE)
Verizon Communications (VZ)
Merck & Co (MRK)
Novartis (NVS)
At&t (T)
Johnson & Johnson (JNJ)
Boston Scientific Corporation (BSX)
Unilever (UL)
Abbott Laboratories (ABT)
Apple (AAPL)
Bank of America Corporation (BAC)
Wells Fargo & Company (WFC)
Tor Dom Bk Cad (TD)
U.S. Bancorp (USB)

View all positions for Astrantus

Top funds holding Cme

Vanguard Group
BlackRock
State Street Corporation
Capital World Investors
Jpmorgan Chase & Co
Geode Capital Management
Bank of New York Mellon
Ameriprise Financial
T. Rowe Price Associates
Invesco
Fil
Northern Trust
Amundi
Guardcap Asset Management
Fiera Capital Corporation

View all funds holding Cme